Acarix A/S (ACARIX) - Net Assets

Latest as of December 2025: Skr38.17 Million SEK ≈ $4.11 Million USD

Based on the latest financial reports, Acarix A/S (ACARIX) has net assets worth Skr38.17 Million SEK (≈ $4.11 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr48.33 Million ≈ $5.20 Million USD) and total liabilities (Skr10.16 Million ≈ $1.09 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ACARIX asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Skr38.17 Million
% of Total Assets	78.98%
Annual Growth Rate	8.78%
5-Year Change	-62.04%
10-Year Change	-75.46%
Growth Volatility	343.63

Acarix A/S - Net Assets Trend (2014–2025)

This chart illustrates how Acarix A/S's net assets have evolved over time, based on quarterly financial data. Also explore ACARIX total asset value for the complete picture of this company's asset base.

Annual Net Assets for Acarix A/S (2014–2025)

The table below shows the annual net assets of Acarix A/S from 2014 to 2025. For live valuation and market cap data, see how much is Acarix A/S worth.

Year	Net Assets	Change
2025-12-31	Skr38.17 Million ≈ $4.11 Million	-49.57%
2024-12-31	Skr75.70 Million ≈ $8.15 Million	+45.89%
2023-12-31	Skr51.88 Million ≈ $5.58 Million	+0.12%
2022-12-31	Skr51.83 Million ≈ $5.58 Million	-48.46%
2021-12-31	Skr100.54 Million ≈ $10.82 Million	+22.41%
2020-12-31	Skr82.14 Million ≈ $8.84 Million	+7.22%
2019-12-31	Skr76.60 Million ≈ $8.24 Million	-12.83%
2018-12-31	Skr87.88 Million ≈ $9.46 Million	-31.85%
2017-12-31	Skr128.94 Million ≈ $13.88 Million	-17.09%
2016-12-31	Skr155.52 Million ≈ $16.74 Million	+1181.13%
2015-12-31	Skr12.14 Million ≈ $1.31 Million	-19.73%
2014-12-31	Skr15.12 Million ≈ $1.63 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Acarix A/S's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 60046800000.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component	Amount	Percentage
Common Stock	Skr11.65 Million	30.51%
Other Comprehensive Income	Skr2.44 Million	6.39%
Other Components	Skr686.27 Million	1797.88%
Total Equity	Skr38.17 Million	100.00%

Acarix A/S Competitors by Market Cap

The table below lists competitors of Acarix A/S ranked by their market capitalization.

Company	Market Cap
Inbest Prime IV Inmuebles SOCIMI S.A. MC:YINB4	$33.85 Million
POLARIS WORKS Inc KQ:123010	$33.86 Million
Gol Linhas Aéreas Inteligentes S.A NYSE:GOLLQ	$33.88 Million
Cipherlab Co Ltd TWO:6160	$33.88 Million
Gabriel Resources Ltd V:GBU	$33.84 Million
Mendus AB (publ) ST:IMMU	$33.83 Million
Sterling Metals Corp V:SAG	$33.83 Million
Subur Tiasa Holdings Bhd KLSE:6904	$33.83 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Acarix A/S's equity between the two most recent reporting periods.

Equity Growth Insights

From 2024 to 2025, total equity changed from 75,697,000 to 38,171,000, a change of -37,526,000 (-49.6%).
Net loss of 48,091,000 reduced equity.
Share repurchases of 11,105,000 reduced equity.
New share issuances of 11,105,000 increased equity.
Other comprehensive income decreased equity by 2,774,000.
Other factors increased equity by 13,339,000.

Equity Change Factors (2024 to 2025)

Factor	Impact	Contribution
Net Income	Skr-48.09 Million	-125.99%
Share Repurchases	Skr11.11 Million	-29.09%
Share Issuances	Skr11.11 Million	+29.09%
Other Comprehensive Income	Skr-2.77 Million	-7.27%
Other Changes	Skr13.34 Million	+34.95%
Total Change	Skr-	-49.57%

Book Value vs Market Value Analysis

This analysis compares Acarix A/S's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 7.97x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has increased from 0.36x to 7.97x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2014-12-31	Skr0.75	Skr0.27	x
2015-12-31	Skr0.56	Skr0.27	x
2016-12-31	Skr5.96	Skr0.27	x
2017-12-31	Skr2.81	Skr0.27	x
2018-12-31	Skr1.73	Skr0.27	x
2019-12-31	Skr2.02	Skr0.27	x
2020-12-31	Skr0.77	Skr0.27	x
2021-12-31	Skr0.60	Skr0.27	x
2022-12-31	Skr0.20	Skr0.27	x
2023-12-31	Skr0.11	Skr0.27	x
2024-12-31	Skr0.08	Skr0.27	x
2025-12-31	Skr0.03	Skr0.27	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Acarix A/S utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): -125.99%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: -653.32%
• Asset Turnover: 0.15x
• Equity Multiplier: 1.27x
Recent ROE (-125.99%) is below the historical average (-83.84%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2014	-127.02%	0.00%	0.00x	1.21x	Skr-20.72 Million
2015	-102.09%	0.00%	0.00x	1.28x	Skr-13.61 Million
2016	-31.02%	0.00%	0.00x	1.11x	Skr-63.79 Million
2017	-23.09%	-4667.08%	0.00x	1.04x	Skr-42.67 Million
2018	-48.10%	-4128.03%	0.01x	1.08x	Skr-51.06 Million
2019	-60.65%	-2501.83%	0.02x	1.08x	Skr-54.12 Million
2020	-50.58%	-1914.65%	0.02x	1.10x	Skr-49.76 Million
2021	-51.52%	-1377.71%	0.03x	1.18x	Skr-61.86 Million
2022	-148.55%	-1322.31%	0.08x	1.34x	Skr-82.17 Million
2023	-150.02%	-1247.22%	0.10x	1.21x	Skr-83.03 Million
2024	-87.44%	-1067.19%	0.08x	1.07x	Skr-73.76 Million
2025	-125.99%	-653.32%	0.15x	1.27x	Skr-51.91 Million

Industry Comparison

This section compares Acarix A/S's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

Industry: Medical Devices
Average net assets among peers: $188,950,142
Average return on equity (ROE) among peers: -16.90%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Acarix A/S (ACARIX)	Skr38.17 Million	-127.02%	0.27x	$33.84 Million
Arcoma AB (ARCOMA)	$48.66 Million	5.27%	0.68x	$11.55 Million
Bactiguard Holding AB (publ) (BACTI-B)	$387.11 Million	-0.84%	0.62x	$61.64 Million
BICO Group AB (BICO)	$2.31 Million	0.00%	2.47x	$159.82 Million
Boule Diagnostics AB (BOUL)	$295.74 Million	7.87%	0.93x	$14.38 Million
CellaVision AB (CEVI)	$887.58 Million	17.25%	0.23x	$311.10 Million
Clinical Laserthermia Systems AB (publ) (CLS-B)	$26.09 Million	-70.24%	0.12x	$11.57 Million
Chordate Medical Holding AB (CMH)	$25.64 Million	-77.06%	0.22x	$29.05K
C-Rad AB (publ) (CRAD-B)	$29.82 Million	-34.38%	0.50x	$86.08 Million
Duearity AB (DEAR)	$-2.39 Million	0.00%	0.00x	$331.97K

About Acarix A/S

ST:ACARIX Sweden Medical Devices

Market Cap

$33.84 Million

Skr314.47 Million SEK

Market Cap Rank

#23306 Global

#445 in Sweden

Share Price

Skr0.27

Change (1 day)

-2.88%

52-Week Range

Skr0.20 - Skr0.43

All Time High

Skr20.62